P Selby

3.4k total citations
57 papers, 2.5k citations indexed

About

P Selby is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, P Selby has authored 57 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 11 papers in Hematology and 10 papers in Immunology. Recurrent topics in P Selby's work include CAR-T cell therapy research (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Immunotherapy and Immune Responses (4 papers). P Selby is often cited by papers focused on CAR-T cell therapy research (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Immunotherapy and Immune Responses (4 papers). P Selby collaborates with scholars based in United Kingdom, Canada and Netherlands. P Selby's co-authors include Timothy Perren, Rosamonde E. Banks, T J McElwain, Norman F. Boyd, D. Dalley, JA Chapman, Peter Alexander, R Powles, B. Robertson and Beryl Jameson and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Human Molecular Genetics.

In The Last Decade

P Selby

57 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Selby United Kingdom 28 1.0k 637 440 407 320 57 2.5k
Imad A. Tabbara United States 21 1.4k 1.4× 499 0.8× 271 0.6× 761 1.9× 187 0.6× 65 2.5k
James A. Neidhart United States 27 1.5k 1.5× 672 1.1× 805 1.8× 356 0.9× 276 0.9× 75 3.5k
Anand B. Karnad United States 24 1.0k 1.0× 805 1.3× 261 0.6× 141 0.3× 247 0.8× 75 2.5k
Ellen G. Feigal United States 21 1.5k 1.5× 735 1.2× 228 0.5× 142 0.3× 236 0.7× 43 2.8k
Samuel A. Jacobs United States 25 1.4k 1.4× 620 1.0× 273 0.6× 279 0.7× 179 0.6× 143 2.9k
Charles M. Haskell United States 23 786 0.8× 479 0.8× 217 0.5× 135 0.3× 196 0.6× 50 2.0k
Francisco Ayala Spain 24 774 0.8× 492 0.8× 475 1.1× 261 0.6× 287 0.9× 105 2.0k
Cheng‐Hwai Tzeng Taiwan 22 949 0.9× 854 1.3× 178 0.4× 240 0.6× 271 0.8× 82 2.4k
Takahiro Okamoto Japan 34 997 1.0× 695 1.1× 517 1.2× 532 1.3× 1.1k 3.5× 194 3.9k
H. Bier Germany 27 972 1.0× 591 0.9× 376 0.9× 102 0.3× 283 0.9× 108 2.1k

Countries citing papers authored by P Selby

Since Specialization
Citations

This map shows the geographic impact of P Selby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Selby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Selby more than expected).

Fields of papers citing papers by P Selby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Selby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Selby. The network helps show where P Selby may publish in the future.

Co-authorship network of co-authors of P Selby

This figure shows the co-authorship network connecting the top 25 collaborators of P Selby. A scholar is included among the top collaborators of P Selby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Selby. P Selby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hofmann, U., James P.B. O’Connor, Chandra Shekhar Biyani, et al.. (2006). Retroperitoneal metastatic squamous cell carcinoma of the tonsil (with elevated beta human chorionic gonadotrophin): a misdiagnosis as extra-gonadal germ cell tumour. The Journal of Laryngology & Otology. 120(10). 885–887. 7 indexed citations
2.
Harland, Mark, Dorothy C. Bennett, Véronique Bataille, et al.. (1999). Mutation testing in melanoma families: INK4A, CDK4 and INK4D. British Journal of Cancer. 80(1-2). 295–300. 42 indexed citations
3.
Velikova, Galina, Rosamonde E. Banks, A. J. H. Gearing, et al.. (1998). Serum concentrations of soluble adhesion molecules in patients with colorectal cancer. British Journal of Cancer. 77(11). 1857–1863. 82 indexed citations
4.
5.
Velikova, Galina, Rosamonde E. Banks, A. J. H. Gearing, et al.. (1997). Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer. British Journal of Cancer. 76(11). 1398–1404. 54 indexed citations
6.
Banks, Rosamonde E., M A Forbes, Meenu Wadhwa, et al.. (1997). Treatment of metastatic renal cell carcinoma with subcutaneous interleukin 2: evidence for non-renal clearance of cytokines. British Journal of Cancer. 75(12). 1842–1848. 4 indexed citations
7.
Booth, Catherine, et al.. (1997). Stromal and vascular invasion in an human in vitro bladder cancer model.. PubMed. 76(6). 843–57. 50 indexed citations
8.
Cunningham, David, M. Dicato, Jaap Verweij, et al.. (1996). Optimum anti-emetic therapy for cisplatin induced emesis over repeat courses: Ondansetron plus dexamethasone compared with metoclopramide, dexamethasone plus lorazepam. Annals of Oncology. 7(3). 277–282. 18 indexed citations
9.
Stanley, Anthea J., Rosamonde E. Banks, Jennifer Southgate, & P Selby. (1995). Effect of cell density on the expression of adhesion molecules and modulation by cytokines. Cytometry. 21(4). 338–343. 14 indexed citations
10.
Primrose, John, et al.. (1993). The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer. British Journal of Cancer. 67(5). 1132–1135. 56 indexed citations
11.
Bliss, Judith M., P Selby, B. Robertson, & TJ Powles. (1992). A method for assessing the quality of life of cancer patients: replication of the factor structure. British Journal of Cancer. 65(6). 961–966. 17 indexed citations
12.
Perren, Timothy & P Selby. (1992). Current issues in cancer. Biological therapy.. BMJ. 304(6842). 1621–1623. 1 indexed citations
13.
Viner, C., et al.. (1990). Ondansetron ? a new safe and effective antiemetic in patients receiving high-dose melphalan. Cancer Chemotherapy and Pharmacology. 25(6). 449–453. 18 indexed citations
14.
Selby, P, R Powles, Donald Easton, et al.. (1989). The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation. British Journal of Cancer. 59(3). 434–438. 73 indexed citations
15.
Selby, P, S Milan, A Nandi, et al.. (1989). High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's disease. British Journal of Cancer. 59(4). 631–635. 44 indexed citations
16.
Selby, P, et al.. (1989). Tumour necrosis factor: clinical relevance.. PubMed. 8(4). 817–36. 38 indexed citations
17.
Boyd, Norman F., et al.. (1988). Measurement of the clinical status of patients with breast cancer: evidence for the validity of self assessment with linear analogue scales. Journal of Clinical Epidemiology. 41(3). 243–250. 28 indexed citations
18.
Millar, B. C., et al.. (1988). A simple method for culturing myeloma cells from human bone marrow aspirates and peripheral blood in vitro. British Journal of Haematology. 69(2). 197–203. 19 indexed citations
19.
Selby, P, et al.. (1985). Nephrotic syndrome during treatment with interferon.. BMJ. 290(6476). 1180–1180. 63 indexed citations
20.
Powles, R, H.M. Clink, David J. Spence, et al.. (1980). CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION. The Lancet. 315(8164). 327–329. 316 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Imad A. Tabbara Breakdown of academic impact, for papers by James A. Neidhart Breakdown of academic impact, for papers by Anand B. Karnad Breakdown of academic impact, for papers by Ellen G. Feigal Breakdown of academic impact, for papers by Samuel A. Jacobs Breakdown of academic impact, for papers by Charles M. Haskell Breakdown of academic impact, for papers by Francisco Ayala Breakdown of academic impact, for papers by Cheng‐Hwai Tzeng Breakdown of academic impact, for papers by Takahiro Okamoto Breakdown of academic impact, for papers by H. Bier
Rankless by CCL
2026